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BACE1 is the sole secretase for generating b-amy-
loid (Ab) in vivo and is being actively pursued as a
drug target for the treatment of Alzheimer’s disease.
Transmembrane BACE1 exerts its biological activity
by cleaving its membrane-bound cellular substrates.
Here, we reveal that BACE1 directly regulates the
level of membrane-anchored full-length Jagged1
(Jag1), a signaling molecule important for the control
of neurogenesis and astrogenesis, via interaction
with its cognate Notch receptor. We show that shed-
ding of Jag1 is reduced in BACE1 null mice and upre-
gulated Jag1 enhances Notch signaling via cell-cell
juxtacrine interactions. Additional biochemical
assays confirmed that overexpression of BACE1
enhanced cleavage of Jag1. Consequently, BACE1
null mice exhibit a significant increase in astrogene-
sis with a corresponding decrease in neurogenesis
in their hippocampi during early development.
Hence, BACE1 appears to function as a signaling
protease that controls the balance of neurogenesis
and astrogenesis via the Jag1-Notch pathway.INTRODUCTION
BACE1 is widely recognized as the b-secretase that cleaves
amyloid precursor protein (APP) at the N-terminal end of the
b-amyloid peptide (Ab) (Hussain et al., 1999; Lin et al., 2000;
Sinha et al., 1999; Vassar et al., 1999; Yan et al., 1999). An exces-
sive accumulation of Ab results in aggregation andamyloid depo-
sition, one of the two pathological hallmarks present in brains of
Alzheimer disease (AD) patients (Hardy and Selkoe, 2002). AD
transgenic mouse models deficient in BACE1 abrogate the pro-
duction of Ab (Cai et al., 2001; Luo et al., 2001; Roberds et al.,
2001). Hence, inhibition of BACE1 enzymatic activity is being
actively investigated to treat or prevent AD. Because of this sig-
nificant clinical application, knowledge concerning the broad
physiological functions of BACE1 in the human brain is critical
for understanding the full effects of BACE1 manipulations.
BACE1 null mice have been widely utilized for this purpose.
Initial reports demonstrated that BACE1 null mice are mostly40 Cell Reports 4, 40–49, July 11, 2013 ª2013 The Authorsviable and healthy, but recent studies show that BACE1 null
mice exhibit various abnormalities including hypomyelination
(Hu et al., 2006, 2008; Willem et al., 2006), schizophrenia-like
behaviors (Savonenko et al., 2008), epileptic seizures (Hitt
et al., 2010; Hu et al., 2010), and retinal pathology associated
with accumulation of age pigment (Cai et al., 2012). The abol-
ished cleavage of BACE1 substrates, such as neuregulin-1 and
voltage-gated sodium channel b-subunit, may account for the
aforementioned phenotypes in BACE1 null mice (Hu et al.,
2006, 2008, 2010; Kim et al., 2011; Willem et al., 2006).
In this report, we show that young BACE1 null mice exhibited
increased numbers of astrocytes in their hippocampi during
early development. Such an increase in astrocytes relates to
enhanced astrogenesis with a concomitant reduction in neuro-
genesis. We further demonstrate that levels of full-length
Jagged1 (Jag1), a signaling molecule important for the control
of astrogenesis via interaction with its cognate Notch receptor,
are significantly increased in BACE1 null mice. This higher level
of Jag1 in turn activates the Notch pathway by inducing the
expression of genes that favor differentiation of neural precursor
cells to astrocytes. Our biochemical assays show that Jag1 is
shed by BACE1. Hence, we provide evidence that BACE1 regu-
lates the Jag1-Notch pathway and that BACE1 deficiency alters
the balance between astrogenesis and neurogenesis during
early development in the mouse hippocampus.RESULTS
Increased Astrogenesis andDecreasedNeurogenesis in
BACE1 Null Dentate Gyrus
BACE1 is richly expressed by neurons, especially during early
development. In brain, BACE1 ismore enriched in the hippocam-
pus than in the cerebral cortex (Hu et al., 2006). To determine
whether BACE1 affects brain development, we examined fixed
young brain tissues using antibodies specific to different cell
lineages. BACE1 deficiency caused a visible increase in GFAP-
positive astrocytes (Figure 1A). This increase was seen in both
male and female mice and was mostly restricted to the dentate
gyrus of BACE1 null mice, whereas the difference in other brain
regions was less evident (data not shown).
During early developmental stages, GFAP is expressed by
both radial glia and mature astrocytes, and GFAP-positive radial
glia in the subgranular zone of dentate gyrus are recognized
as multipotent neural precursor cells (NPCs) (Doetsch, 2003;
Figure 1. Increased Astrocytes in BACE1
Null Mice
(A) Fixed brain slices were stained with antibodies
specific to GFAP for radial glia and astrocytes
(Smi22, (A). The age of samples is specified in each
panel. Apical radial processes were visibly greater
in P8 BACE null dentate gyrus (middle panel in A),
whereas mature astrocytes were visibly greater in
the polymorph (Po) and molecular (Mo) layers
(middle and right panels in A). The contour of
dentate gyrus is specified by the dashed line.
Scale bar is 10 mm.
(B) Fixed brain slices from P30 mouse brains were
stained with antibodies specific to astrocytes by
S100b for mature astrocytes. Astrocytic pro-
cesses marked by S100b, extending from the
granular layer (gr) to the molecular layer, were
clearly greater in young adult BACE1 null dentate
gyrus than in the wild-type controls. Nuclei were
marked by TO-PRO-3.
(C andD) Stereological quantification of astrocytes
marked by GFAP was performed using mice at
P28. The total astrocytes were calculated from the
entire dentate gyrus in each mouse. The increases
of astrocytes in both the molecular layer (Mo) and
polymorph layer (Po) were significant (n = 6 ani-
mals; *p < 0.05 and **p < 0.01, two-way ANOVA).Malatesta et al., 2008). Depending on the environmental and
developmental cues, radial glia express either the neurogenic
marker proteins SRY-related HMG-box gene 2 (Sox2), double-
cortin, and nestin, or a gliogenic marker such as brain lipid bind-
ing protein (BLBP) (Kempermann et al., 2004; von Bohlen und
Halbach, 2011). With reduced nestin expression, somata of mul-
tipotent radial glia in the subgranular zone will differentiate into
astrocytes and migrate across the granular layer toward the
molecular layer (Brunne et al., 2010). When reaching the border
between the granular and molecular layers, radial glia begin to
express the astrocytic protein S100b. After reaching the molec-
ular layer, GFAP-positive processes in radial glia ramify andCell Reports 4, 4become mature astrocytes. Astrogenesis
usually begins after birth and rodent
astrocytes mature by about 2 weeks of
age (Bushong et al., 2004).
We noted that the increase in GFAP-
labeled cells was relatively small at
postnatal day 3 (P3) (Figure 1A, left).
The increase of radial glia in the granular
layer of P8 BACE1 null dentate gyrus
became evident and more radio-glial
apical processes were extended across
the granular layer (Figure 1A, middle).
At P28, radial glial apical processes in
wild-type (WT) mice were notably less
abundant in the granular layer during
normal growth. However, the intensity
of GFAP-positive apical processes re-
mained abundant in BACE1 null dentate
gyrus, indicating that higher numbers ofradial glia are present. Moreover, the number of mature astro-
cytes with spongiform processes, marked by GFAP antibody in
the polymorph and molecular layers, was significantly greater
in BACE1 null dentate gyrus. This increase of mature astro-
cytes in BACE1 null mice was also evident if astrocytes were
labeled with S100b antibody (Figure 1B). Further stereological
quantification, based on the examination of P28 mouse brains,
confirmed increases in total dentate astrocytes by 28.2% in
the molecular layer and 15.7% in the polymorph layer (Fig-
ure 1C; 13,567.3 ± 795.2 astrocytes per BACE1/ molecular
layer versus 10,580.9 ± 511.6 astrocytes per WT molecular
layer; 7,798.5 ± 53.2 astrocytes per BACE1/ polymorph layer0–49, July 11, 2013 ª2013 The Authors 41
Figure 2. Decreased Number of Mature Neurons in BACE1 Null Mice
(A) Fixed brain slices from the indicated age of mouse brains were stained with antibodies specific to NeuN. The number of mature neurons in BACE1 null dentate
gyrus was visibly smaller than in the wild-type controls. Scale bar is 10 mm.
(B) Stereological quantification of total mature neurons marked by NeuN was performed using mice at P28. The reductions of neuronal number in the granular
layer (Gr) and polymorph layer are displayed in separate bars (n = 6 animals; **p < 0.01, two-way ANOVA).versus 6,740.8 ± 272.5 astrocytes per WT polymorph layer;
n = 6 animals, p < 0.05). In addition, we also calculated the
astrocyte density (defined as astrocyte numbers per mm3) in
the molecular and polymorph layers and found increases by
approximately 41.2% and 48.1% of astrocyte density in the
BACE1 null molecular and polymorph layers, respectively (Fig-
ure 1D; 64,857.8 ± 4,419.2 in the BACE1/ molecular layer
versus 45,972.6 ± 2,330.8 in the WT molecular layer;
130,901.2 ± 1,287.4 in the BACE1/ polymorph layer versus42 Cell Reports 4, 40–49, July 11, 2013 ª2013 The Authors88,353.0 ± 3,533.8 in the WT polymorph layer; n = 6 animals,
p < 0.01).
In contrast, the number of mature neurons, labeled with the
NeuN antibody, was visibly reduced in BACE1 null mice (Fig-
ure 2A). The reduction in mature neurons in BACE1 null mice
was visible at the early ages of P3 and P8. A stereological quan-
tification using samples from P28 mice showed reductions
of neurons by 24.1% in the granule layer and 30.9% in the
polymorph layer (Figure 2B; 106,045.7 ± 2,722.8 neurons per
Figure 3. Increased Radial Glia in BACE1 Null Mice
(A) Fixed brain slices were treated with antibodies to GFAP and BLBP, both being expressed by radial glia in the dentate gyrus. Somata of radial glia have a
triangular shape (specified by circles) and the processes marked by both GFAP and BLBP usually projected toward the granular layer. Radial glia near the border
of the granular and molecular layers usually differentiate into astrocytes, which have typical ramified processes in the molecular layers (single colored picture in
Figure S1). Scale bar is 30 mm.
(B) Comparison of GFAP and BLBP double-positive radial glia in WT and BACE1/ dentate gyrus was performed using a similar stereological quantification as
described in Figure 1. Significantly greater numbers of total radial glia were present in BACE1 null dentate gyrus (n = 5 animals; **p < 0.01, two-way ANOVA).
(C) The protein level of BLBP was gradually reduced during postnatal growth. During early development, expression of BACE1 was also higher in P3 samples
(compared to P20 samples). Increased protein levels of BLBP were evident in BACE1 null mice. Actin served as a loading control.
(D) Bar graphs represent a relative quantification of western blots. A significant increase of BLBP was observed in all three ages of BACE1 null samples (n = 3
independent experiments; **p < 0.01, two-way ANOVA).
See also Figure S1.BACE1/ granular layer versus 139,648.2 ± 5046.7 neurons per
granular layer of WT mice; 5,999.0 ± 290.8 neurons per
BACE1/ polymorph layer versus 8,676.8 ± 406.7 neurons
per polymorph layer of WT; n = 6 animals, p < 0.01).
To determine whether the increase in astrocytes is due to a
shift in the differentiation of multipotent radial glia, we examined
the expression of BLBP, which is spatially and temporally regu-
lated during radial glial proliferation and differentiation (Feng
et al., 1994). We found that BLBP-labeled radial glia in subgranu-
lar zones of BACE1 null mice were significantly increased
(Figure S1). BLBP and GFAP double-positive radial glia, recog-
nizable by triangularly shaped somata (specified by circles in
Figure 3A), were more readily identified in the BACE1 null gran-
ular layer of dentate gyrus than in the same region of WT mice.
Quantification of BLBP and GFAP double-positive radial glia
confirmed an increase by 54.4% in P8 and 91.2% in P20
BACE1 null mice, respectively (Figure 3B; P8: 4,468.8 ± 347.9
radial glia per BACE1/ dentate gyrus versus 2,893.8 ± 238.5
radial glia per WT dentate gyrus; P20: 3,761.7 ± 305.8 radial
glia per BACE1/ dentate gyrus versus 1,967.2 ± 202.7 radial
glia per WT dentate gyrus; n = 5 animals, p < 0.01). Moreover,
the increased BLBP-positive cells in BACE1 null brain sections
were also reflected by increased protein levels of BLBP in those
mice (Figure 3C). Although BLBP protein levels in mouse hippo-
campi were developmentally reduced from P3 to P20 in parallelwith the declined differentiation of BLBP-positive radial glia into
astrocytes (Brunne et al., 2010), BLBP protein levels in BACE1
null hippocampi in all three age groups were higher than that in
the corresponding age-matched control group (Figure 3D).
Together, these results suggest that more radial glia differentiate
into mature astrocytes in BACE1 null mice, whereas neurogene-
sis is reduced during early developmental stages.
Altered Fates of NPCs in BACE1 Null Dentate Gyrus
To determine whether increased GFAP and BLBP double-posi-
tive radial glia in BACE1 null mice were due to an increase in
dividing NPCs, we performed a pulse labeling experiment by
intraperitoneally injecting BrdU in mice at the age of P18. After
a 12 hr pulse, the total number of BrdU-positive cells was not
noticeably different between the two groups in the basal region
of the granular layer, and this was further confirmed by stereo-
logical quantification (Figure 4A; 7,538.8 ± 353.2 cells per WT
dentate gyrus versus 7,011.3 ± 324.0 per BACE1/ dentate
gyrus; n = 5 animals). Despite similar numbers of NPCs in the
subgranular zone, BrdU-positive cells in BACE1 null mice were
also found in the polymorph layer and molecular layer, whereas
labeled NPCs in WT dentate gyrus were mostly restricted to the
subgranular zone (Figure 4A). This observation appears unique
to BACE1 null mice, which clearly indicates a differential fate in
dividing NPCs.Cell Reports 4, 40–49, July 11, 2013 ª2013 The Authors 43
Figure 4. Increased Astrogenesis and Reduced Neurogenesis in BACE1 Null Mice
(A) A single injection of BrdU was administered to P18 mice and BrdU-incorporated dividing cells were detected by an antibody specific to BrdU by immuno-
histochemical staining. BrdU-positive dividing cells were mainly seen in the subgranular zone, whereas some BrdU-positive cells were also seen in the molecular
layer in BACE1 null mice. Scale bars = 40 mm. BrdU-positive dividing cells only in the subgranular zone were quantified from each mouse by using the
(legend continued on next page)
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For fate determination of BrdU-positive cells, P11 mice were
intraperitoneally injected with BrdU daily for 5 consecutive days
and sacrificed at P30 for analysis. In treated WT mice, BrdU
and GFAP double-positive dividing radial glia were restricted
to the subgranular zone of dentate gyrus (Figure 4B, top). Dur-
ing early developmental stages, these radial glia migrate in both
directions (i.e., across the granular layer) to form astrocytes
with a typical morphology of mature astrocytes in the
molecular layer (Brunne et al., 2010). We noted that the
numbers of BrdU and GFAP double-positive astrocytes were
visibly greater in the BACE1 null molecular layer compared to
that in the WT molecular layer (Figure 4B). Quantitative analysis
further revealed that BrdU and GFAP double-positive astro-
cytes were almost double (increased by 97.4%) in BACE1 null
dentate molecular and polymorph layers compared to WT con-
trols (Figure 4C; 2,444.2 ± 78.0 in BACE1/ versus 1,238.3 ±
64.4 in WT; n = 5 animals, p < 0.01). Moreover, BACE1 defi-
ciency resulted in a higher percentage of dividing NPCs to
differentiate into astrocytes in the dentate gyrus (Figure 4C;
15.9% ± 0.8% in BACE1/ versus 7.5% ± 0.8% in WT; n =
5 animals, p < 0.01).
On the other hand, significantly fewer multipotent radial glia
adopted the fate of neurogenesis in forming BrdU and NeuN
double-positive cells, which are primarily located in the granular
layer in BACE1 null mice (Figure 4B, bottom). This reduced neu-
rogenesis was confirmed by the 23% decrease of BrdU and
NeuN double-positive neurons in the BACE1 null dentate gran-
ular layer (Figure 4C; 8,575.7 ± 492.4 granule cells in BACE1/
versus 11,134.5 ± 749.2 granule cells in WT; n = 5, p < 0.01). A
reduction in neurogenesis in BACE1 null brain was further
evidenced by a smaller percentage of BrdU-positive NPCs
differentiating into neurons compared to WT animals (Figure 4C;
55.7% ± 3.3% in BACE1/ versus 70.5% ± 1.8% in WT; n = 5,
p < 0.01, Student’s t test). Together, our data indicate that
BACE1 deficiency favors astrogenesis by increasing the per-
centage of multipotent radial glia to differentiate into astrocytes.
Increased Jagged1-Notch Signaling in BACE1 Null Mice
To explore the molecular mechanism underlying enhanced
astrogenesis in BACE1 null mice, we examined a panel of pro-
teins important for astrogenesis. We found that Notch activation
was significantly increased, as increased NICD production was
evident in BACE1 null mice (Figure 5A). We also observed that
the activity of Notch was greater in the WT P3 hippocampus
and gradually weakened during early mouse growth, as NICD
levels were lower from P3 to P10 to P20 (Figure 5A). In BACE1
null mice, NICD levels were increased in each of these three
age groups compared toWTmice (Figure 5B), indicating a higher
Notch signaling activity with BACE1 deficiency.stereological quantification. The number represents the total BrdU-positive cells in
cells in this region did not differ significantly (n = 5 animals; Student’s t test).
(B) P11 mice were injected with BrdU once per day for 5 consecutive days and b
antibodies to BrdU (red) and GFAP or NeuN. BrdU+/GFAP+-positive astrocytes w
these astrocytes were observed in BACE1 null dentate gyrus. BrdU+/NeuN+-pos
zone. Scale bar = 30 mm.
(C) The quantified total double-positive astrocytes or neurons from each dentate g
over the total BrdU single-positive cells are also shown in bar graphs. N = 5 animNotch activation is normally mediated by cell-cell interactions
with Notch on one cell and its membrane-anchored ligand,
belonging to the DSL (Delta/Serrate/Lag-2) family, on neigh-
boring cells (Kopan and Ilagan, 2009). Interactions between the
extracellular domains of DSL ligands and the Notch receptor
trigger subsequent proteolytic cleavage of Notch and the release
of NICD. To determine how Notch becomes more active in
BACE1 null mice, we examined the levels of Serrate/Jagged 1
(Jag1) and Jagged 2 (Jag2), two main ligands expressed by
hippocampal neurons during early mouse development (Stump
et al., 2002). Although changes in Jag2 were not evident (data
not shown), protein levels of full-length Jag1 were significantly
elevated in BACE1 null hippocampi (Figure 5A), and this reduced
processing of Jag1 was statistically significant (Figure 5C). It has
been previously demonstrated that only membrane-anchored
Jag1 has the capacity to mediate Notch activation via cell-cell
juxtacrine signaling and specific ectodomain shedding of Jag1
appears to downregulate Jag1 signaling activity (Kopan and
Ilagan, 2009). Hence, our data suggest an enhanced Jag1-Notch
signaling activity in BACE1 null mice via reduced proteolytic pro-
cessing of Jag1.
BACE1 Regulates Jag1 Signaling Activity via Proteolysis
BACE1, a type I transmembrane aspartyl protease, is pre-
dicted to shed its substrates residing on the membrane (Yan
et al., 2001). We therefore examined whether Jag1 is directly
cleaved by BACE1 by performing western blot analysis on
HEK293 cells cotransfected with BACE1 and Jag1. Previously,
Jag1 was shown to be shed by a-secretase in cultured cells
(Ikeuchi and Sisodia, 2003; LaVoie and Selkoe, 2003), and
ADAM17 appears to be active in processing Jag1 (Boyer-Di
Ponio et al., 2007; Parr-Sturgess et al., 2010). We noted that
overexpressed BACE1 cleaved Jag1, as production of Jag1
C-terminal fragment (Jag1-ctf) was increased in cells coex-
pressing BACE1 and Jag1 (Figure 5D). Similar increases in
Jag1-ctf levels were also observed in cells coexpressing
ADAM17 and Jag1. When Jag1 was expressed in HM cells,
which stably overexpress HA-tagged BACE1, only one Jag1-
ctf band was visible because of high BACE1 activity
(Figure 5E). Treatment of the transfected cells with metallopro-
tease inhibitor GM6001 slightly increased the level of Jag1-ctf.
If BACE1 activity was inhibited by BACE1 inhibitor IV, full-
length Jag1 was increased. Noticeably, Jag1-ctf migrated
faster, suggesting increased a-secretase cleavage under this
condition (shown in the long exposed condition; Figure 5E,
middle). Blocking g-secretase activity using DAPT resulted in
accumulation of two Jag1-ctf fragments in the low-exposure
condition (specified in arrowheads in Figure 5E).
These results indicated that the slower migrating Jag1-ctf isthe basal subgranular region per dentate. The difference in total BrdU-positive
rains were examined at P30. The brain sections were treated with monoclonal
ere mainly in the molecular and polymorphic layers, and significantly more of
itive cells were mainly localized in the granular layer, including the subgranular
yrus are quantified. The percentages of double-positive astrocytes or neurons
als; p < 0.01, Student’s t test.
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Figure 5. Altered Jag1-Notch Signaling in
BACE1 Null Mice
(A) Protein lysates from hippocampi were used
for comparing levels of the indicated proteins.
The level of NICD is developmentally regulated
and increased NICD was seen in three age
groups of BACE1 null mice compared to wild-
type controls. Full-length Jag1 was elevated in
BACE1 null mice, whereas ErbB4 levels were not
changed.
(B and C) The relative protein levels of NICD and
Jag1 are presented as bar graphs. Three separate
experiments were performed and the results were
used for quantification (**p < 0.01, two-way
ANOVA).
(D) The Rat Jag1 expression construct was
transfected with empty vector or together with
BACE1 or ADAM17 in HEK293 cells and protein
lysates were examined by western blot analysis.
A significant increase in the processed Jag1
C-terminal fragment (Jag1-ctf) was visible in both
BACE- and ADAM17-expressing cells.
(E) Jag1 was transiently transfected in HM cell
line, which was generated by stably over-
expressing BACE1 in HEK293 cells. The trans-
fected cells were then treated with BACE1
inhibitor IV, a-secretase inhibitor GM6001, or
g-secretase inhibitor DAPT. Jag1-ctfa and Jag1-
ctfb stand for a-secretase- and BACE1-cleaved
fragments, respectively.
See also Figure S2.a BACE1-cleaved product. We thus designated these two
bands as Jag1-ctfa and Jag1-ctfb.
DISCUSSION
BACE1 was the first-discovered membrane-anchored aspartyl
protease in the vertebrate system; its rich expression in the46 Cell Reports 4, 40–49, July 11, 2013 ª2013 The Authorsneuron and in early developmental stages
implies the importance of this protein in
various brain functions. In this study, we
showed that BACE1 effectively cleaves
Jag1, a member of the DSL protein fam-
ily. In BACE1 null mice, levels of full-
length Jag1 were significantly increased.
Our functional study shows that the
increased full-length Jag1 shifts the bal-
ance of astrogenesis and neurogenesis.
Given that a proper balance between
neurogenesis and gliogenesis is impor-
tant for brain function, BACE1 is undoubt-
edly an important molecule in the control
of normal brain functions.
In the developing mammalian brain,
differentiation into neurons from NPCs
begins at the embryonic stage, whereas
differentiation into astroglia from NPCs
begins postnatally. During neonatal
mouse development, the Notch signalingpathway has been implicated to control the switch of NPC differ-
entiation to gliogenesis by irreversibly inhibiting neurogenesis
(Ever and Gaiano, 2005; Morrison et al., 2000). Notch can be
activated by interaction with a membrane-anchored ligand
such as Jag1 through cell-cell juxtacrine interactions (Kopan
and Ilagan, 2009). Although several transmembrane-anchored
Notch ligands such as Delta, Jag1, and Jag2 can potentially
activate Notch, Jag1 appears to be the predominant ligand ex-
pressed in the early developmental dentate gyrus (Stump
et al., 2002). Jag1 was indeed predominantly expressed by neu-
rons (Figure S2), andwe do not yet know the contribution of other
Notch ligands. Noticeably, NICDwas detected in P0 and P3 nes-
tin-positive hippocampal NPCs (Figure S3), consistent with a
prior report that Notch is expressed by NPCs in the early devel-
opmental hippocampus (Stump et al., 2002).
Enhanced astrogenesis in BACE1 null mice was observed in
the P3-BACE1 null mouse hippocampal dentate gyrus, and
this became gradually more evident, as increased GFAP-posi-
tive astrocytes in the P28 mouse dentate gyrus were greater in
the molecular and polymorph layers of BACE1 null dentate gyrus
compared to WT (Figure 1A). Numbers of mature astrocytes,
marked by S100b antibody, were also greater in BACE1 null
dentate gyrus than in WT (Figure 1B). Such an increase in astro-
genesis appeared to be due to enhanced differentiation of multi-
potent radial glia to adopt an astrogenesis fate. We observed
that a significant portion of radial glia migrated across the
granular layer of BACE1 null mice and that this migration was
significantly greater than in WT mice (Figures 2 and S1). We
also quantified diving radial glia neural stem cells (one section
from every ten sections and a total of six sections from each
animal). Notably, BrdU-positive dividing cells in WT dentate gy-
rus were mostly localized in the subgranular zone. We found that
the number of BrdU-positive cells after a 12 hr pulse was slightly
greater in BACE1 null mice than in their WT littermates. Quanti-
fication showed that this increase was mainly in the molecular
layer and polymorphic layer because the total radial glia neural
stem cells in subgranular zone were not changed significantly
based on our stereological quantification shown in Figure 4A.
In the molecular or polymorph layer, our BrdU-labeling results
showed that these astrocytes express GFAP (Figure 4B),
S100b, or Adlh1 (data not shown), confirming that mature astro-
cytes are differentiated from radial glia. On the other hand, BrdU
and NeuN double-positive mature neurons were mainly local-
ized in the granular layer (Figure 4C), indicating that these
BrdU-positive radial glia in the subgranular zone would predom-
inantly form granule cells. Hence, enhanced astrogenesis
apparently reduces neurogenesis in BACE1 null mice, presum-
ably due to lateral inhibition of neurogenesis due to enhanced
NICD levels.
In the P3 BACE1 null dentate gyrus, the numbers of mature
neurons marked by NeuN antibody in the entire dentate gyrus
were clearly smaller than in WT controls (Figure 2A). Although
the gap was narrowed by P28, the reduction of neurogenesis
never recovered to normal levels. Hence, we provide evidence
that BACE1 controls the balance of hippocampal astrogenesis
and neurogenesis and that increased astrogenesis can impair
normal neurogenesis.
Our biochemical assays indicate that Jag1 is a cellular sub-
strate of BACE1 as cleavage of Jag1 by BACE1 is reduced
when BACE1 is inhibited (Figure 5). Correspondingly,
enhancing cleavage of Jag1 is seen upon BACE1 overexpres-
sion. On the western blot, it appeared that BACE1- and
ADAM17-cleaved Jag1 C-terminal fragments migrate almost
identically. Our recent in vitro assays have further confirmed
that the cleavage sites of Jag1 by ADAM17 and BACE1 areindeed in close proximity (data not shown). Similarly, BACE1-
and ADAM10- cleaved Neuregulin-1 products, separated by
only eight amino acids, are also not readily separable (Luo
et al., 2011). Additional mutagenesis studies and in vitro map-
ping experiments are being conducted for further validation.
During early development, both BACE1 (various prior publica-
tions) and Jag1 (Figure S2) are expressed by neurons. BACE1
deficiency clearly causes reduced shedding of Jag1 by
enhancing full-length Jag1 levels (Figure 5). In turn, the upregu-
lated Jag1 signaling will activate Notch, which is expressed by
radial glial cells to release NICD; NICD was found to coexist
with nestin in neural stem cells during early development (Fig-
ure S3). Hence, our data demonstrate that BACE1 functions
as a signaling protease that controls the Jag1-Notch signaling
pathway.
In summary, BACE1 exerts its physiological functions via the
regulated processing of its cellular substrates. In this study, we
show that the Jag1-Notch signaling pathway is regulated by
BACE1 activity. Given that BACE1 is one of the most promising
drug targets for Alzheimer therapy, it is logical to ask whether
BACE1 inhibition will affect neurogenesis. Despite the impor-
tance of BACE1 in balancing astrogenesis and neurogenesis,
the Jag1-Notch pathway is more active during early develop-
mental stages and less active in the adult; BACE1 activity is
significantly higher during early development than in the adult
(Figure 3C). Increased astrocytes during early developmental
stages are expected to have long-lasting effects on brain func-
tions. It is known that astrocytes, the most abundant cell type
in the brain, regulate synaptic function and plasticity by close
association with synapses (Clarke and Barres, 2013). Although
it is unclear whether an increased number of astrocytes in the
dentate gyrus will significantly affect synaptic function, reduced
neurogenesis potentially affects neuronal functions. BACE1 null
mice display both impaired long-term depression and a specific
deficit in mossy fiber long-term potentiation (Wang et al.,
2008) as well as epileptic seizures (Hu et al., 2010). We postulate
that these deficits are related to the altered neurogenesis and
astrogenesis in BACE1 null mice. Looking ahead, it will be
important to determine whether the inhibition of BACE1 will
have a significant effect in the adult on the hippocampal func-
tions that are associated with the altered astrogenesis and neu-
rogenesis observed in this study.
EXPERIMENTAL PROCEDURES
Animals
BACE1 Null Mice
Generation of BACE1 null mice was described by Cai et al. (2001), and the col-
onies went through at least ten congenic breedings with C57Bl6 mice. The
primers (HC69: 50-AGGCAGCTTTGTGGAGATGGTG-30; HC70: 50-
CGGAAATCGGAAAGGCTACTCC-30; and HC77: 50-TGGATGTGGAAT
GTGTGCGAG-30) were used to genotype BACE1–null mice (Cai et al., 2001).
The primer pair (50-TGAAAAGCTGCACCTCATTG-30 and 50-CTGGTTGACCT
GAGCTGTGA-30) was used to amplify a DIG-labeled 544 bp DNA fragment
for Southern blotting (Roche Applied Science), whichwas used to ensure com-
plete deletion of BACE1 in BACE1 null mice.
All experimental protocols were approved by the Animal Care andUse Com-
mittee at the Cleveland Clinic in compliance with the guidelines established by
the Public Health Service Policy on Humane Care and use of Laboratory
Animals.Cell Reports 4, 40–49, July 11, 2013 ª2013 The Authors 47
Cell Proliferation and Differentiation Analyses
To analyze neural differentiation, 15 mg/kg of BrdU was injected once daily
for 5 days beginning at P11 (four WT versus four BACE1 null mice). The
animals were sacrificed after an additional 14 days, and brain sections were
examined with double labeling by using primary antibodies against BrdU
and SMI22 (clones: Mab1B4, Mab2E1 and Mab4A11; Sternberger) or BrdU
and NeuN (clone: MAB377; Chemicon). Labeled cells were quantified by
stereology.
Immunofluorescent Confocal Microscopy
Confocal experiments were performed according to standard methods as
previously described (He et al., 2004). After transcardial perfusion with 4%
paraformaldehyde, the mouse brain was surgically removed and immersed
in 20% sucrose overnight at 4C. Brains were sagittally cut into 16-mm-
thick sections on a freezing microtome (Microm GmbH). Sections were
permeabilized with 0.3% Triton X-100 for 30 min. After being rinsed in PBS
three times to remove the detergent, the sections were heated by micro-
wave in 0.05 M citrate-buffered saline (pH 6.0) for 5 min, blocked with 5%
normal goat serum, and incubated with individual primary antibodies at
the following dilutions: SMI22 (1:1,000), S100b (1:500; Sigma), Aldh1L1 (1:3;
clone: N103/39; NeuroMab), BLBP (1:1,000; Millipore), and NeuN (1:1,000).
After washing with PBS three times, sections were incubated with secondary
antibodies conjugated with Alexa Fluor 488 or Alexa Fluor 568 (Molecular
Probes).
Stereological Quantification
Volume of the Dentate Gyrus
Serial 20 mm frozen coronal sections were cut through the rostrocaudal extent
of the hippocampus. The volume of the dentate gyrus was evaluated on every
tenth section through the rostrocaudal extent of the dentate gyrus. After Nissl
staining, the whole hippocampal image was captured by a Leica DMR micro-
scope with a QImaging Retiga-2000R CCD camera using a 2.53 objective to
take P28 mice hippocampal images. The volumes of the molecular layer,
granular layer, and polymorph layer of the dentate gyrus were measured using
Cavalieri’s direct estimator (Gundersen et al., 1988b). Briefly, the area of
each layer in the dentate gyrus was measured (mm2) using ImageJ software,
according to the boundary criteria of Franklin and Paxinos (1997) for the
mouse. The total volume of each layer in the dentate gyrus was calculated
from V = SA 3 T 3 10, where SA is the sum of the layer area, T is the section
thickness, and 10 is the periodicity of the section sample.
Cell Number in the Dentate Gyrus
Serial sections through the rostrocaudal extent of the dentate gyrus were
selected at ten-section intervals for immunofluorescent staining with the
primary antibody anti-NeuN or anti-GFAP and counterstaining with TO-
PRO-3 to mark nuclei. For neural differentiation experiments, the selected
sections were double-immunofluorescently stained with NeuN/BrdU and
GFAP/BrdU. Cells in different layers of the dentate gyrus were captured by a
Leica SP5 confocal microscope using a 403 oil objective. Images were
collected by z series through a distance of 10 mm in 2 mm steps beginning
at 2 mm from the section surface. Cells with labeled nuclei were counted
using ImageJ software. The number (NV) of specific labeled cells (NeuN-,
GFAP-, BrdU-, NeuN/BrdU-, and GFAP/BrdU-positive cells) was determined
in each layer of the dentate gyrus using the optical disector method (Gun-
dersen et al., 1988a), Nv = SQ/SVDis, where SQ is the sum of the cells
counted and SVDis is the sum of the disector volumes. The disector volume
was calculated from VDis = ADis 3 h, where ADis is the area of the counting
layer and h is the disector height (10 mm, the z axis length of focus). The
total cell number (N) in each layer of the dentate gyrus was calculated from
N = NV 3 V.
Proteolytic Cleavage of Jag1
For cultured cells, rat Jag1 expression construct (generous gift from the lab
of Dr. Raphael Kopan) was transfected together with an empty vector,
BACE1, or ADAM17 expression construct in HEK293 cells for 24–48 hr.
ADAM17 expression construct (pRK5F-TACE; #31713) was obtained from
Addgene (Liu et al., 2009). Protein lysates were prepared according to stan-
dard procedures and equal amounts of protein were used for western blotting48 Cell Reports 4, 40–49, July 11, 2013 ª2013 The Authorsanalysis with primary antibodies (BLBP, 1:1,000; BACE1, 1:1,000; cleaved
Notch1, 1:500, Cell Signaling; ErbB4, 1:1,000, Upstate; Jagged1, 1:200, Santa
Cruz; HA antibody, 1:1,000, Roche; both anti-actin in 1:5,000 and anti-Flag in
1:1,000, Sigma).SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and can be found with this
article online at http://dx.doi.org/10.1016/j.celrep.2013.06.005.
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